Brown Brothers Harriman & Co’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-12,217
Closed -$1.21M 1366
2019
Q3
$1.21M Buy
12,217
+2,159
+21% +$205K 0.01% 210
2019
Q2
$930K Buy
10,058
+406
+4% +$38.6K 0.01% 223
2019
Q1
$911K Sell
9,652
-449
-4% -$39.3K 0.01% 213
2018
Q4
$647K Buy
10,101
+127
+1% +$9.38K ﹤0.01% 221
2018
Q3
$893K Buy
9,974
+712
+8% +$62.9K 0.01% 208
2018
Q2
$736K Sell
9,262
-188
-2% -$15.6K ﹤0.01% 202
2018
Q1
$843K Buy
9,450
+96
+1% +$9.22K ﹤0.01% 200
2017
Q4
$976K Buy
9,354
+158
+2% +$17.8K 0.01% 187
2017
Q3
$1.34M Sell
9,196
-310
-3% -$42.2K 0.01% 158
2017
Q2
$1.24M Buy
9,506
+169
+2% +$20.7K 0.01% 155
2017
Q1
$1.16M Buy
9,337
+110
+1% +$13.2K 0.01% 159
2016
Q4
$1.07M Sell
9,227
-15,459
-63% -$1.72M 0.01% 161
2016
Q3
$2.58M Sell
24,686
-10,429
-30% -$1.13M 0.01% 123
2016
Q2
$3.46M Sell
35,115
-424
-1% -$43.9K 0.02% 111
2016
Q1
$3.56M Buy
35,539
+21
+0.1% +$2.16K 0.02% 107
2015
Q4
$4.25M Sell
35,518
-2,838
-7% -$328K 0.02% 103
2015
Q3
$4.15M Sell
38,356
-1,357
-3% -$168K 0.02% 105
2015
Q2
$4.6M Sell
39,713
-1,054
-3% -$120K 0.02% 100
2015
Q1
$4.7M Buy
40,767
+591
+1% +$70.6K 0.02% 101
2014
Q4
$4.49M Sell
40,176
-6,912
-15% -$729K 0.02% 107
2014
Q3
$4.46M Sell
47,088
-15,950
-25% -$1.44M 0.02% 111
2014
Q2
$5.41M Buy
63,038
+21,082
+50% +$1.6M 0.02% 109
2014
Q1
$2.93M Buy
41,956
+2,958
+8% +$234K 0.01% 125
2013
Q4
$3.29M Buy
38,998
+5,338
+16% +$422K 0.01% 120
2013
Q3
$2.59M Sell
33,660
-17,708
-34% -$1.24M 0.01% 126
2013
Q2
$3M Buy
+51,368
New +$3.09M 0.01% 137

Other funds holding CELG

Brown Brothers Harriman & Co's CELG Position: Q4 2019 in Review

Brown Brothers Harriman & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 12,217 shares — an estimated $1.21M sold.

Brown Brothers Harriman & Co first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $5.41M in Q2 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Brown Brothers Harriman & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 12,217 Celgene Corp shares in Q4 2019, an estimated $1.21M.
  • Brown Brothers Harriman & Co first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Brown Brothers Harriman & Co's Celgene Corp position peaked at $5.41M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2019, filed 14 Feb 2020.